SCHEMBL30501200

SCHEMBL30501200

NC(=O)c1nc(-c2cn[nH]c2)ccc1-c1cc(N2CCOCC2)ccc1N1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 2/20 0.46
▸ CDK2 P24941 2/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ PIK3CD O00329 2/20 0.39
▸ CCNA2 P20248 1/20 0.39
▸ CCNA1 P78396 1/20 0.39
▸ BMPR1B O00238 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ BMPR1A P36894 1/20 0.38
▸ ACVR1B P36896 1/20 0.38
▸ TGFBR1 P36897 1/20 0.38
▸ ACVRL1 P37023 1/20 0.38
▸ TGFBR2 P37173 1/20 0.38
▸ ACVR1 Q04771 1/20 0.38
▸ BMPR2 Q13873 1/20 0.38
▸ PRKAB1 Q9Y478 1/20 0.38
▸ LRRK2 Q5S007 5/20 0.38
▸ MAPT P10636 2/20 0.37
▸ JAK2 O60674 2/20 0.37
▸ CSF1R P07333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30501446 0.94 IRAK4 (0.46) IRAK4CDK2GSK3BPIK3CDCCNA2
SCHEMBL30501359 0.93 IRAK4 (0.45) IRAK4CDK2GSK3BPIK3CDCCNA2
SCHEMBL30501499 0.87 JAK2 (0.44) IRAK4PIK3CDJAK2ALDH1A1PIK3CA
SCHEMBL30501230 0.86 CHEK1 (0.48) IRAK4HDAC6
SCHEMBL30501443 0.86 CDK2 (0.40) IRAK4CDK2GSK3BPIK3CDCCNA2
SCHEMBL30501447 0.86 PIK3CD (0.41) IRAK4CDK2GSK3BPIK3CDCCNA2
SCHEMBL30501341 0.86 JAK2 (0.45) IRAK4CDK2GSK3BCCNA2CCNA1
SCHEMBL30501226 0.85 CDK2 (0.42) IRAK4CDK2GSK3BPIK3CDCCNA2
SCHEMBL30501355 0.85 IRAK4 (0.45) IRAK4CDK2GSK3BPIK3CDLRRK2
SCHEMBL30501208 0.85 IRAK4 (0.43) IRAK4CSF1RHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032642-B Kinase inhibitors and methods of making and using the same 里格尔药品股份有限公司 2023-07-18 — — CN claimed
CN-111032642-B Kinase inhibitors and methods of making and using the same 里格尔药品股份有限公司 2023-07-18 — — CN disclosed
Send feedback